ClinicalTrials.Veeva

Menu

The Clinical Utility of QuantiFERON in the Diagnosis of Active Tuberculosis

A

Armed Forces Capital Hospital, Republic of Korea

Status

Completed

Conditions

Tuberculosis

Study type

Observational

Funder types

Other

Identifiers

NCT00982969
QFTinROKmilitary

Details and patient eligibility

About

The investigators will evaluate the usefulness of QuantiFERON-TB Gold in-tube (QFT) in the diagnosis of active tuberculosis in young adults group, highly clinically suspected tuberculosis.

Full description

Investigators will enroll prospectively all clinically and radiologically suspected tuberculosis patients from 20 to 29 years old who visited the Armed Forces Capital Hospital. Investigators will perform QFT and tuberculin skin test. Diagnosis of tuberculosis will be made by World Health Organization guideline and the physician will not know the QuantiFERON-TB Gold in-tube results before the diagnosis and anti-tuberculosis medication. Investigators will evaluate the sensitivity and specificity of QuantiFERON-TB Gold in-tube in the diagnosis of active tuberculosis among young adults.

Enrollment

200 estimated patients

Sex

Male

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • All clinically and radiologically suspected TB patients from 20 to 29 years old who visited the Armed Forces Capital Hospital

Exclusion criteria

  • Soldiers who do not agree with study protocol

Trial design

200 participants in 1 patient group

TB suspected
Description:
Soldiers who are clinically suspected with tuberculosis

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems